<div>References</div><div>1. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With
Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.<i>JAMA Cardiol.</i> Published online March 25, 2020.
doi:10.1001/jamacardio.2020.0950</div><div>Lippi G., Plebani M. Laboratory abnormalities in patients with
COVID-2019 infection. Clin Chem Lab Med. 2020.</div><ol><li>Y. Zhang, M. Xiao, S. Zhang, P. Xia, W. Cao, W. Jiang, H. Chen, X.
Ding, H. Zhao, H. Zhang, C. Wang, J. Zhao, X. Sun, R. Tian, W. Wu, D.
Wu, J. Ma, Y. Chen, D. Zhang, J. Xie, X. Yan, X. Zhou, Z. Liu, J.
Wang, B. Du, Y. Qin, P. Gao, X. Qin, Y. Xu, W. Zhang, T. Li, F. Zhang,
Y. Zhao, Y. Li, S. Zhang, Coagulopathy and Antiphospholipid Antibodies
in Patients with Covid -19, N. Engl. J. Med. (2020).
https://doi.org/10.1056/NEJMc2007575</li><li>F.A. Klok, et al., Thrombosis Research,
https://doi.org/10.1016/j.thromres.2020.04.013</li><li>Fox, Sharon &amp; Akmatbekov, Aibek &amp; Harbert, Jack &amp; Li, Guang &amp;
Brown, J. &amp; Heide, Richard. (2020). Pulmonary and Cardiac Pathology
in Covid-19: The First Autopsy Series from New Orleans.
10.1101/2020.04.06.20050575.</li><li>Tang, N., Bai, H., Chen, X., Gong, J., Li, D. and Sun, Z. (2020),
Anticoagulant treatment is associated with decreased mortality in
severe coronavirus disease 2019 patients with coagulopathy. J Thromb
Haemost. Accepted Author Manuscript.
doi:10.1111/jth.14817</li></ol>